Forging Hopeful Futures to Reduce Youth Violence
Launched by UNIVERSITY OF PITTSBURGH · Feb 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The trial titled "Forging Hopeful Futures to Reduce Youth Violence" is studying a special program designed to help young people, aged 13 to 19, prevent violence and improve their coping and communication skills. This program focuses on important social issues like race, gender, and economic fairness. By participating, teens will have the opportunity to learn how to handle conflicts and express themselves better, all while being part of a supportive community.
To join the study, participants must be between 13 and 19 years old, speak English, and either live, go to school, or use facilities in certain neighborhoods involved in the trial. Participants will be asked to provide their contact information for follow-up. The program is currently looking for volunteers, and it's a chance for young people to gain valuable skills while contributing to important research on reducing violence in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants must be ages 13-19 (inclusive)
- • 2. Participants must speak English
- • 3. Participants must live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
- • 4. Participants must be able to provide follow up contact information
- Exclusion Criteria:
- • 1. Not ages 13 -19 (inclusive)
- • 2. Do not speak English
- • 3. Do not live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
- • 4. Unable to provide follow up contact information
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Alison Culyba, MD PhD MPH
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials